Adding impetus to the innovative development of biopharmaceuticals - The 14th Five Year Plan and 2035 Vision Outline for Expanding and Strengthening the Bioeconomy propose to accelerate the development of industries such as biopharmaceuticals, biological breeding, biomaterials, and bioenergy, and to expand and strengthen the biopharmaceutical industry. The biopharmaceutical industry is a strategic emerging industry that is related to national economy, people's livelihood, and national security, covering multiple aspects such as biotechnology industry, pharmaceutical industry, and biomedical engineering industry. In recent years, guided by favorable policies, China's biopharmaceutical industry has entered a fast lane of development, with a series of new products and services providing new assistance to ensure people's lives and health. Looking at the industry, there has been a significant increase in R&D investment across the entire industry, with thousands of new drugs entering clinical trials and hundreds of new drugs conducting international multicenter clinical trials. The number of approved new drugs is increasing day by day. Looking at enterprises, traditional pharmaceutical enterprises are accelerating their transformation pace, constantly laying out innovative drug research and development, and a large number of emerging biotechnology companies are gradually established and growing rapidly. These innovative entities are important forces in promoting the innovative development of biopharmaceuticals, gathering industry experts and analyzing cutting-edge developments. As of the end of 2022, there are 4120 biopharmaceutical related enterprises in Xi'an High tech Zone, and the scale of the biopharmaceutical industry has exceeded 60 billion yuan, Located at the forefront of the Central Western National High tech Zone, the China (Xi'an) Biomedical and Technology Equipment Exhibition was hosted by the Airport New City Management Committee of Xixian New Area in Shaanxi Province and hosted by Zhongkai International Exhibition (Beijing) Co., Ltd. on April 25, 2024, at the Xi'an Airport Convention and Exhibition Center. The exhibition will continue to adhere to the development concept of openness, innovation, cooperation, and win-win, continuously explore and break through the innovation of biopharmaceutical technology and industry, promote the development of the medical device industry, and create an innovative leader in China's biopharmaceutical industry. We will comprehensively integrate various forms of activities such as exhibition displays, annual innovative product selection and commendation, summit forums, new product releases, procurement conferences, training and exchanges, and strive to create a cutting-edge platform for showcasing and promoting the biopharmaceutical and related industries to the country and even the world.

• Company:Zhongkai International Exhibition (Beijing) Co., Ltd
• Truename:Chang Kai
• Mobile:15649211206
• E-mail:1852546692@qq.com
• Address:15 Guangren West Road, Airport New City, Xixian New Area, Xianyang City, Shaanxi Province

The information on this site comes from the network and related members, and the website has done its duty to review it. Due to the uncontrollability of the process of organizing the exhibition, some of the exhibition information in the station may change the subject matter, Extending or cancelling the event, please exhibitors and visitors must check with each other again before exhibiting! All the exhibitions in this site are not hosted/co-organized or organized, if there are any disputes during the exhibition, please hold the main responsibility of the exhibition organization! QQ Email: 523138820@qq.com WeChat: 523138820 Mobile: 15313206870